1. Home
  2. NNN vs IBRX Comparison

NNN vs IBRX Comparison

Compare NNN & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NNN REIT Inc.

NNN

NNN REIT Inc.

HOLD

Current Price

$43.50

Market Cap

8.5B

Sector

Real Estate

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.19

Market Cap

7.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNN
IBRX
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
7.5B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
NNN
IBRX
Price
$43.50
$7.19
Analyst Decision
Hold
Strong Buy
Analyst Count
7
7
Target Price
$44.50
$12.57
AVG Volume (30 Days)
1.4M
14.3M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
5.47%
N/A
EPS Growth
N/A
38.71
EPS
2.07
N/A
Revenue
$926,213,000.00
$113,288,000.00
Revenue This Year
$5.14
$88.59
Revenue Next Year
$4.64
$131.15
P/E Ratio
$21.21
N/A
Revenue Growth
6.55
668.31
52 Week Low
$38.90
$1.83
52 Week High
$46.03
$12.43

Technical Indicators

Market Signals
Indicator
NNN
IBRX
Relative Strength Index (RSI) 47.08 44.66
Support Level $41.61 $2.22
Resistance Level $45.67 $8.28
Average True Range (ATR) 0.66 0.57
MACD -0.01 0.01
Stochastic Oscillator 13.08 20.17

Price Performance

Historical Comparison
NNN
IBRX

About NNN NNN REIT Inc.

NNN REIT Inc is a real estate investment trust that acquires, owns, invests in, and develops high-quality properties mainly leased under long-term net leases with minimal capital expenditure requirements. The company focuses mainly on retail properties, with a portfolio including convenience stores, automotive service properties, restaurants, theatres, entertainment venues, dealerships, and other retail-related assets. Primary business objectives emphasize retail properties, and it may invest in a wide variety of property and tenant types, leases, mortgages, loans secured by personal property, loans secured by partnership or membership interests, and securities of other REITs or other issuers.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: